Logo del repository
  1. Home
 
Opzioni

Bioactive Lipid Metabolites in Amanita Virosa.

CATENI, FRANCESCA
•
ZACCHIGNA, MARINA
•
DRIOLI, Sara
altro
Piltaver, A.
2011
  • conference object

Abstract
Amanita fungi are the main lethal toadstool among the 1000 poisonous mushrooms known in the world. Thrombin is the key serine proteinase of the coagulation cascade and therefore a suitable target for inhibition of blood coagulation. An extract of Amanita virosa considerably inhibited thrombin (48%) and showed no inhibitory activity on trypsin. On the basis of inhibition selectivity between thrombin and trypsin and potency of thrombin inhibition, Amanita virosa constituted a good starting material for isolation of further compounds that are active against thrombin. In a preliminary study, 95 selected mushroom species have been screened in order to find novel specific non-peptidic thrombin inhibitors. The extract of Amanita virosa considerably inhibited thrombin (48% at concentration of 120 μg/mL). A bioassay oriented fractionation of the extract of Amanita virosa has led to the isolation of active compounds. On the basis of spectroscopic data, chemical reactions and GCMS analysis, complex mixtures of triglycerides, monoacylglycerols, free fatty acids and ergosterol have been isolated and identified.
Archivio
http://hdl.handle.net/11368/2831991
Diritti
metadata only access
Soggetti
  • Amanita virosa, mushr...

Visualizzazioni
4
Data di acquisizione
Apr 19, 2024
Vedi dettagli
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback